Angiotensin II for the Treatment of COVID-19–Related Vasodilatory Shock

Coronavirus disease 2019 (COVID-19) first appeared in Wuhan, China, in early December 2019.1 Since then, the World Health Organization has classified it as a pandemic and, as of April 16, 2020, 186 countries have reported over 2 million confirmed cases and 138,000 deaths.2 In the cohort of patients with severe disease, 89.0% were hospitalized and 8.1% died.1 In the subgroup of patients admitted to the intensive care unit (ICU), required...